Friday, June 28, 2024
HomeTagsEHA 2022

EHA 2022

EHA 2022 | Ascentage Pharma Releases Encouraging Results of Bcl-2 Inhibitor Lisaftoclax (APG-2575)

Ascentage Pharma , a global biopharmaceutical company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and age-related diseases, announced that it...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics